Guizhou Yibai Pharmaceutical Co.,Ltd.’s Net Profit Dropped 3.2% in First Half of 2023

Guizhou Yibai Pharmaceutical Co.,Ltd. (贵州益佰制药股份有限公司) (600594.SH) reported a net profit of 121.7 million yuan in the first half of 2023, down 3.2% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, up 2.3% year-on-year.

At the end of the reporting period, it had 5 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 33.8%.